JP2024543479A5 - - Google Patents
Info
- Publication number
- JP2024543479A5 JP2024543479A5 JP2024528455A JP2024528455A JP2024543479A5 JP 2024543479 A5 JP2024543479 A5 JP 2024543479A5 JP 2024528455 A JP2024528455 A JP 2024528455A JP 2024528455 A JP2024528455 A JP 2024528455A JP 2024543479 A5 JP2024543479 A5 JP 2024543479A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- compound
- acceptable salt
- compound according
- alternatively
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163279094P | 2021-11-13 | 2021-11-13 | |
| US63/279,094 | 2021-11-13 | ||
| US202163282264P | 2021-11-23 | 2021-11-23 | |
| US63/282,264 | 2021-11-23 | ||
| US202263299749P | 2022-01-14 | 2022-01-14 | |
| US63/299,749 | 2022-01-14 | ||
| US202263317980P | 2022-03-09 | 2022-03-09 | |
| US63/317,980 | 2022-03-09 | ||
| US202263321915P | 2022-03-21 | 2022-03-21 | |
| US63/321,915 | 2022-03-21 | ||
| US202263336476P | 2022-04-29 | 2022-04-29 | |
| US63/336,476 | 2022-04-29 | ||
| US202263375050P | 2022-09-08 | 2022-09-08 | |
| US63/375,050 | 2022-09-08 | ||
| PCT/US2022/049719 WO2023086580A2 (en) | 2021-11-13 | 2022-11-11 | Multicyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543479A JP2024543479A (ja) | 2024-11-21 |
| JP2024543479A5 true JP2024543479A5 (https=) | 2025-11-18 |
Family
ID=86336491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024528455A Pending JP2024543479A (ja) | 2021-11-13 | 2022-11-11 | 多環式化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250100987A1 (https=) |
| EP (1) | EP4429656A4 (https=) |
| JP (1) | JP2024543479A (https=) |
| CA (1) | CA3238026A1 (https=) |
| IL (1) | IL312774A (https=) |
| WO (1) | WO2023086580A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024226703A2 (en) * | 2023-04-27 | 2024-10-31 | The Scripps Research Institute | Asymmetric synthesis and diversification of a stabilized salvinorin a scaffold |
| CN118267384B (zh) * | 2024-03-27 | 2024-12-20 | 徐州医科大学 | κ阿片受体激动剂在制备预防和/或治疗颞叶癫痫药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090088466A1 (en) * | 2005-06-17 | 2009-04-02 | University Of Iowa Research Foundation | Opioid receptor ligands |
| US11512075B2 (en) * | 2017-06-14 | 2022-11-29 | The Scripps Research Institute | Synthesis of 20-nor-salvinorin A |
| US20210186927A1 (en) * | 2018-04-13 | 2021-06-24 | Blumentech, S.L. | Combination product for the induction and/or maintenance of general anesthesia |
| US10556889B1 (en) * | 2018-12-19 | 2020-02-11 | Blue Sky Pharmaceuticals, LLC | Salvinorin derivatives |
-
2022
- 2022-11-11 IL IL312774A patent/IL312774A/en unknown
- 2022-11-11 CA CA3238026A patent/CA3238026A1/en active Pending
- 2022-11-11 EP EP22893676.1A patent/EP4429656A4/en active Pending
- 2022-11-11 WO PCT/US2022/049719 patent/WO2023086580A2/en not_active Ceased
- 2022-11-11 US US18/707,895 patent/US20250100987A1/en active Pending
- 2022-11-11 JP JP2024528455A patent/JP2024543479A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024050527A5 (https=) | ||
| JP6100439B2 (ja) | アンドロゲン受容体調節薬のエステル誘導体およびそれらの使用のための方法 | |
| JP2024543479A5 (https=) | ||
| JP2007538024A5 (https=) | ||
| BR112013002164B1 (pt) | Inibidores de desmetilase à base de arilciclopropilamina de lsd1, seus usos, e composição farmacêutica | |
| WO2012072713A2 (en) | Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae | |
| JP2015535249A (ja) | アルツハイマー病と関連疾患の治療のための併用療法 | |
| JP2022519131A5 (https=) | ||
| JP2008539268A5 (https=) | ||
| TW201908298A (zh) | 胺烷基苯並硫氮呯衍生物之用途 | |
| JP2015505301A5 (https=) | ||
| JP2022541780A (ja) | Ｎｌｒｐ３インフラマソーム阻害剤としての化合物と組成物とその使用 | |
| RU2004104329A (ru) | Ацилсемикарбазиды как ингибиторы циклинзависимой киназы, полезные в качестве противораковых и противопролиферативных агентов | |
| JP2009521417A5 (https=) | ||
| WO2012011103A2 (en) | METHODS AND COMPOSITIONS FOR INHIBITING THE NUCLEAR FACTOR kB PATHWAY | |
| JP2021091670A5 (https=) | ||
| RU2007125659A (ru) | Фенилпиперазиновые производные с сочетанием свойств неполного агонизма к рецепторам дофамина-d2 и ингибирования повторного поглощения серотонина | |
| CN113439080A (zh) | 作为pd-l1免疫调节剂的乙烯基吡啶甲酰胺基化合物 | |
| JP2024517443A (ja) | がんの治療に有用なモレファンチン誘導体 | |
| CA2635093A1 (en) | Derivatives of sulindac, use thereof and preparation thereof | |
| RU2008108175A (ru) | Комбинация соединений, которые можно использовать при лечении респираторных заболеваний, особенно хронической оструктивной болезни легких (copo) и астмы | |
| RU2018141584A (ru) | Триазолы для регуляции гомеостаза внутриклеточного кальция | |
| WO2024189592A9 (en) | Sephin1 and related compounds for the treatment of diseases and disorders amenable to treatment by ampk activation and/or chop inhibition | |
| JP2018504391A5 (https=) | ||
| JP2023549394A5 (https=) |